Ranking Member's News

11.02.16

Senators Urge Rejection Of Proposed Chinese Purchase Of U.S. Aluminum Producer

WASHINGTON -- In a letter sent to President Barack Obama today, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., led 12 senators who urged the Committee on Foreign Investment in the United States to reject the proposed purchase of Aleris Co., by China-based Zhongwang International Group. Senators Chuck Schumer, D-N.Y., Bob Casey, D-Penn., Joe Manchin, D-W.V., Kirsten Gillibrand, D-N.Y., Joe Donnelly, D-Ind., Rob Portman, R-Ohio, Debbie Stabenow, D-Mich., Jeff Merkley, D-Ore., Amy Klob… Continue Reading


11.01.16

Wyden Statement on Tax Avoidance Strategies Reportedly Used by Donald Trump

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after reports that Donald Trump used legally-dubious strategies to dodge taxes in the early 1990s: "Every story that comes out about Donald Trump's reported tax dodging and ties to Russia is a fresh reminder of the outrageous fact that he is refusing to release his tax returns to the public. There is a week to go before election day and millions of votes have already been cast, but Mr. Trump is still… Continue Reading


10.26.16

Leahy, Wyden Alarmed By Decreased DEA Enforcement Of Pharmaceutical Distributors

WASHINGTON - Senate Judiciary Committee Ranking Member Patrick Leahy, D-Vt., and Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to Attorney General Loretta Lynch following reports published by the Washington Post concerning the Justice Department's oversight of major pharmaceutical distributors that dispense opioid-based pain drugs . The reports detail the slowdown of diversion enforcement by the Drug Enforcement Administration (DEA). The reports also include tr… Continue Reading


10.24.16

Wyden Looks To Tighten Sanctions On Syria

WASHINGTON - In an effort to investigate ways the U.S. could further isolate the government of Bashar al Assad and pressure him to end his campaign of violence against his own nation, Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today requested detailed information from the Treasury Department on sanctions in place against the Syrian regime and the strategies intended to prevent shell companies from evading those sanctions. "Like many in this country, I am deeply concerned by the … Continue Reading


10.21.16

Wyden, Crapo Call for Fairness for U.S. Jobs and Rural Communities in Softwood Lumber Deal

WASHINGTON -- In a letter sent to President Barack Obama today, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senator Mike Crapo, R-Idaho, and 22 other Senators called for any new softwood lumber agreement with Canada to protect U.S. timber jobs and communities. "Hundreds of thousands of U.S. jobs and thousands of U.S. rural communities depend on fairness in trade in softwood lumber. That is why we will continue to urge you, and any future Administration, to seek a fair, effective… Continue Reading


10.19.16

Wyden Kicks Off Inquiry To Test Disclosure Laws For Shell Companies

WASHINGTON - In an effort to assess the effectiveness of federal disclosure requirements intended to fight the misuse use of shell companies, Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today sent a letter to the heads of the Treasury Department and IRS requesting detailed reports on filings by the thousands of firms linked to the Panama Papers. "I remain extremely concerned about the use of shell companies to evade taxes, commit financial crimes, and defraud the government at th… Continue Reading


10.18.16

Wyden Statement on 2017 COLA and Medicare Part B Premiums

Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following the announcement of a 0.3 percent Cost of Living Adjustment (COLA) increase in 2017. The increase is expected to raise premiums significantly for some in Medicare Part B. "Seniors in Medicare expect their health costs to be affordable and stable, and I'll be looking at every option in the days ahead to make sure that remains the case," Wyden said. A "hold harmless" provision of the Social Security Act… Continue Reading


10.13.16

Wyden Statement on Section 385 Regulations

Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today issued the following statement on Section 385 regulations issued by the Treasury Department: "These final rules on Section 385 clearly reflect a lot of input and careful study, and in my view they will go a long way to protecting our corporate tax base. What this does not change is the need for tax reform. For too long Congress has sat on a broken and outdated tax system, which is why the U.S. has resorted to rule changes to respo… Continue Reading


10.12.16

Wyden Statement On End Of US-Canada Softwood Lumber Standstill Period

WASHINGTON -- Senate Finance Committee Ranking Member Ron Wyden, D-Ore., issued the following statement on efforts to resolve longstanding differences between the United States and Canada over subsidies to Canadian lumber production. A one-year pause on filing new trade cases over softwood subsidies ends at midnight tonight. "Unless Canada can fulfill the principles agreed to by its Prime Minister and President Obama in July, it may soon be too late to strike an agreement on softwood lumber tra… Continue Reading


10.12.16

Wyden Report: Opioid Funds Lacking, Nationwide Epidemic Will Continue to Rage

WASHINGTON - Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released a report outlining the consequences of underfunding treatment for opioid addiction, now an epidemic across the United States. Earlier this year, Congress passed the Comprehensive Addiction and Recovery Act of 2016 (CARA), but provided no funds to the policies it authorized. Additionally, Congress has not acted on the White House-requested $920 million that would expand access to treatment in states as part of … Continue Reading


10.07.16

Wyden Statement on Mylan Settlement

Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today issued the statement below following news that Mylan NV will pay $465 million to the Department of Justice and other agencies to settle the question of whether the company had for years been vastly underpaying EpiPen rebates owed to Medicaid. "Today's news is a first step for taxpayers to get what they are owed from drug companies. I remain extremely concerned by the alarming trend of rising drug prices straining family budgets an… Continue Reading


10.05.16

Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades

WASHINGTON - Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and House Energy and Commerce Committee Ranking Member Frank Pallone, Jr. D-N.J., today issued a statement following a letter from Centers for Medicare & Medicaid Services (CMS) Acting Administrator Andy Slavitt regarding the misclassification of EpiPen as a generic drug for nearly two decades: "Today's letter is more evidence that while Mylan irresponsibly raised the price of EpiPen, they were also bilking taxpayers ou… Continue Reading


09.29.16

Wyden Warns of China's Destructive Impact on U.S. Aluminum Sector

WASHINGTON - Senate Finance Committee Ranking Member Ron Wyden, D-Ore., warned of the damage to U.S. workers in the aluminum sector caused by China's trade-distorting industrial policies, in testimony he submitted to a U.S. International Trade Commission hearing today. The ITC held the hearing to evaluate competitive conditions affecting the U.S. aluminum industry, following massive closures affecting primary aluminum facilities in several states and ongoing challenges related to unfairly traded… Continue Reading


09.29.16

Senators Celebrate Planned Parenthood’s First 100 Years

Washington, D.C. - Senator Ron Wyden, D-Ore., today led 18 of his Senate colleagues in introducing a resolution to recognize the importance of Planned Parenthood's contributions to women's health care and reproductive rights in America over the last 100 years. Planned Parenthood will celebrate 100 years of providing care and information to millions of women about their reproductive health on October 16. The organization today provides a wide array of reproductive health services, including prev… Continue Reading


09.28.16

Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades

WASHINGTON - Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and House Energy and Commerce Committee Ranking Member Frank Pallone, Jr. D-N.J., today issued a statement following a letter from Centers for Medicare & Medicaid Services (CMS) Acting Administrator Andy Slavitt regarding the misclassification of EpiPen as a generic drug for nearly two decades: "Today's letter is more evidence that while Mylan irresponsibly raised the price of EpiPen, they were also bilking taxpayers ou… Continue Reading

Showing page   of 219
Results per Page:

Follow The Ranking Member